Cited by 58Inflammatory Bowel DiseaseImmune responses and vaccinationsRheumatoid Arthritis Research and Therapies

Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease

Open access
Marín, Alicia C·2015·World Journal of Gastroenterology

Abstract

Inflammatory bowel disease (IBD) is an immunological disorder that is usually treated with immunosuppressive therapy, potentially leading to increases in vulnerability to infections. Although many infections can be prevented by vaccination, vaccination coverage in these patients in clinical practice is insufficient. Therefore, the seroprotection condition should be verified, even for routine vaccines, such as hepatitis B or pneumococcus. Response to vaccines in IBD patients is thought to be impaired due to the immunological alterations generated by the disease and to the immunomodulatory treatments. The immunogenicity of hepatitis B, influenza, and pneumococcal vaccines is impaired in IBD patients, whereas the response to papillomavirus vaccine seems similar to that observed in the healthy population. On the other hand, data on the immunogenicity of tetanus vaccine in IBD patients are conflicting. Studies assessing the response to measles-mumps-rubella, varicella, and herpes zoster vaccines in IBD patients are scarce. The cellular and molecular mechanisms responsible for the impairment of the response to vaccination in IBD patients are poorly understood. Studies aiming to assess the response to vaccines in IBD patients and to identify the mechanisms involved in their immunogenicity are warranted. A better understanding of the immune response, specifically to vaccines, in patients with immune-mediated diseases (such as IBD), is crucial when developing vaccines that trigger more potent immunologic responses.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3748/wjg.v21.i40.11273

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Reduced immunogenicity of HBV and influenza vaccines in IBD patients is thought to be influenced by this immunological impairment, but underlying pathomechanism remains to be elucidated.

    “This is thought to influence the reduced immunogenicity of HBV and influenza vaccines in IBD patients, for which the underlying pathomechanism remains to be elucidated (Marín et al., 2015).”

    From Viral Infections, the Microbiome, and Probiotics (2021) · cites this paper as Marín et al., 2015

  • IBD patients, either UC or CD, are at higher risk of viral infections and require specific antiviral care including sero-surveillance, vaccination and anti-infective therapies.

    “IBD patients, either ulcerative colitis (UC) or Crohn’s disease (CD), are at higher risk of viral infections and therefore require specific antiviral care including sero-surveillance, vaccination and anti-infective therapies.”

    From Viral Infections, the Microbiome, and Probiotics (2021) · cites this paper as Marín et al., 2015

  • Increased viral infection risk in IBD is due to immunological impairment induced by both pathophysiology and immuno-modulating medications.

    “This increased risk is due to immunological impairment induced by both the pathophysiology of the disease and immuno-modulating medications (Marín et al., 2015; Magro et al., 2017).”

    From Viral Infections, the Microbiome, and Probiotics (2021) · cites this paper as Marín et al., 2015

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Marín, A. C.
Affiliations
Hospital Universitario de La Princesa (ES)
Corresponding author
Marín, Alicia C
Venue
World Journal of Gastroenterology
Published
2015
Volume
21
Issue
40
Pages
11273
ISSN
1007-9327 (ISSN-L)
OpenAlex
W2337226296
Cited by
58
References
78
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 11 · 2021: 13 · 2020: 7 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 1
FWCI
0.42
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • World Journal of Gastroenterology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords
inflammatory bowel disease, vaccine immunogenicity, immunosuppressive therapy, hepatitis B vaccine, pneumococcal vaccine, influenza vaccination, papillomavirus vaccine, tetanus vaccine, MMR vaccine, varicella vaccine, herpes zoster vaccine, seroprotection, infection control, immune-mediated diseases
MeSH terms
Antibodies, Colitis, Ulcerative, Crohn Disease, Humans, Immunization Schedule, Immunosuppressive Agents, Serologic Tests, Vaccination, Vaccines, Attenuated, Vaccines, Inactivated, Biomarkers, Immunocompromised Host

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review